STAR & BMI: Can thigh muscle and fat measurements predict knee pain relief after a nerve block
Official title: Sonographic Thigh Adjustment Ratio and Subcutaneous Fat Thickness as Predictors of Genicular Nerve Block Response in Patients With Knee Osteoarthritis Undergoing Genicular Nerve Block: A Prospective Observational Study
Run by Gaziosmanpasa Research and Education Hospital · NCT07712419 · Data updated 2026-11-12
This study tests whether ultrasound measurements of thigh muscle and subcutaneous fat can help predict who will have pain relief after a genicular nerve block for knee osteoarthritis.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 45 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Gaziosmanpasa Research and Education Hospital Government |
| Locations | 1 site (Istanbul) |
| Status | Recruiting |
| Started | August 5, 2026 |
| Main results expected | February 2027 |
| Study ends | February 2027 |
| Registry record updated | October 20, 2026 |
| Trial ID | NCT07712419 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 45 and older with symptomatic bilateral knee osteoarthritis (Kellgren-Lawrence grade 3–4) who are scheduled for their first ultrasound-guided genicular nerve block and meet criteria.
✕Probably not a fit
Patients without a predictive relationship between STAR/subcutaneous fat and pain relief may not experience improved selection for GNB.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective observational study will enroll adults with symptomatic knee osteoarthritis undergoing their first ultrasound-guided genicular nerve block. Before the procedure, ultrasound will measure anterior quadriceps thickness and subcutaneous fat to calculate the Star ratio (STAR) as muscle thickness divided by BMI, along with other body-fat metrics. Clinical outcomes, including pain and function, will be tracked after the block to see if STAR or fat measurements correlate with treatment response. The goal is to identify imaging biomarkers that help select patients who are most likely to benefit from GNB. The study does not involve altering standard care beyond data collection. Findings could improve patient selection and personalize interventional pain management approaches.
Why it matters
Potential benefit: If STAR and related measurements reliably predict response, clinicians could better identify patients who are likely to benefit from GNB.
How similar studies have gone: Ultrasound-based muscle and fat metrics are emerging biomarkers, but this specific predictive approach for interventional knee pain procedures is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥45 years. * Symptomatic bilateral knee osteoarthritis with Kellgren-Lawrence grade 3 or 4. * Visual Analog Scale (VAS) pain score ≥4 at rest or during movement. * Scheduled to undergo first ultrasound-guided genicular nerve block. * No intra-articular knee injection within the previous 3 months. * Considered unsuitable for or awaiting total knee arthroplasty. * Ability to provide written informed consent. Exclusion Criteria: * Inflammatory arthritis, rheumatoid arthritis, or crystal arthropathy. * Previous knee surgery or knee prosthesis. * Active local or systemic infection. * Anticoagulant therapy or bleeding disorders. * Contraindication to corticosteroids (including uncontrolled diabetes mellitus). * Allergy to study medications. * Neurological disorders causing neuropathic knee pain. * Dementia or inability to complete study assessments. * Additional interventional procedures or surgery during follow-up.
Where it's running
-
University of Health Sciences Gaziosmanpaşa Physical Therapy and Rehabilitation Training and Research Hospital
Istanbul, Turkey (Türkiye) Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nerve branches to the vastus medialis added to genicular nerve treatment for chronic knee pain
This observational study tests whether adding pulsed radiofrequency to the nerve branches near the vastus medialis to standard genicular nerve treatment helps people with chronic knee osteoarthritis pain.
-
Effects of virtual reality on walking in adults with knee osteoarthritis
This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Preoperative Multimorbidity and Functional Recovery After Total Knee Arthroplasty
This study tests whether higher burden of preoperative multimorbidity affects functional recovery after knee replacement in adults with knee osteoarthritis.
-
Cartilage biomarker response to acute loading in knee OA by antiresorptive treatment status
Researchers will test whether a 30-minute treadmill walk changes cartilage biomarkers in postmenopausal women with knee osteoarthritis, comparing those on denosumab, bisphosphonates, and those not on antiresorptives.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.